跳至主要内容
临床试验/ITMCTR2100004535
ITMCTR2100004535招募中1 期

Chinese Herbal Formula Xingqi Zhitong for Acute Radiation-Induced Esophagitis in Esophageal Cancer: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Shanxi Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 85(—)
性别
All

入选标准

  • 1. Those with a confirmed diagnosis of esophageal squamous cell carcinoma by gastroscopy and pathological cytohistology (AJCC 8th edition).
  • 2. Age greater than 18 years.
  • 3. Patients without indications for surgery or refusing surgery.
  • 4. No previous radiation therapy.
  • 5. No contraindication to radiation therapy.
  • 6. ECOG (Eastern Cooperative Oncology Group) score 0-2.
  • 7. Those with expected survival time > 12 weeks.
  • 8. Those who signed the informed consent form.

排除标准

  • 1. Complete esophageal obstruction, deep esophageal ulcer, esophageal perforation or vomiting of blood.
  • 2. History of surgery within 28 days prior to baseline.
  • 3. Participation in other interventional clinical trials within 30 days.
  • 4. Pregnant and lactating women.
  • 5. Those with severe cardiac, pulmonary, hepatic, or renal abnormalities, or immunodeficiency.
  • 6. Those with uncontrollable psychiatric disorders, tumor metastatic disease (according to the AJCC 8th edition M1b).
  • 7. Any other condition that the investigator deems the patient unsuitable for the clinical trial.

研究者

发起方
Shanxi Provincial Hospital of Chinese Medicine

相似试验